Nurofen told to withdraw ad claims about ‘targeted relief’


Pain relief brand Nurofen has been reprimanded by the Therapeutic Goods Administration over its claims of “targeted relief”.

The Reckitt Benckiser brand was brought before the complaints resolution panel of the TGA over claims in the ad, made by Havas Worldwide, that Nurofen targets the source or cause of pain.

In a decision, the TGA upheld the complaints and ordered that the brand withdraw “any representations that the advertised products target the source of pain or cause of pain”.

Targeted ReliefIt also ordered that the brand withdraw advertising that claims to travel directly to or target specific sites on the body.

Be a member to keep reading

Join Mumbrella Pro to access the Mumbrella archive and read our premium analysis of everything under the media and marketing umbrella.

Become a member

Get the latest media and marketing industry news (and views) direct to your inbox.

Sign up to the free Mumbrella newsletter now.

"*" indicates required fields

 

SUBSCRIBE

Sign up to our free daily update to get the latest in media and marketing.